Plasma DNA and Vascular Remodelling in Patients With Sickle Cell Disease

NCT02721472 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

44

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

PROCEDURE: micro- and macro-circulatory vascular remodelling measures not practice in routine care
PROCEDURE: Biological measures not practice in routine care

Sponsor

Theravia